162 related articles for article (PubMed ID: 18467647)
1. Intracellular localization of Cthrc1 characterizes differentiated smooth muscle.
Leclair RJ; Wang Q; Benson MA; Prudovsky I; Lindner V
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1332-8. PubMed ID: 18467647
[TBL] [Abstract][Full Text] [Related]
2. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration.
Pyagay P; Heroult M; Wang Q; Lehnert W; Belden J; Liaw L; Friesel RE; Lindner V
Circ Res; 2005 Feb; 96(2):261-8. PubMed ID: 15618538
[TBL] [Abstract][Full Text] [Related]
3. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation.
LeClair RJ; Durmus T; Wang Q; Pyagay P; Terzic A; Lindner V
Circ Res; 2007 Mar; 100(6):826-33. PubMed ID: 17322174
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1).
Durmus T; LeClair RJ; Park KS; Terzic A; Yoon JK; Lindner V
Gene Expr Patterns; 2006 Oct; 6(8):935-40. PubMed ID: 16678498
[TBL] [Abstract][Full Text] [Related]
5. Array profiling reveals contribution of Cthrc1 to growth of the denervated rat urinary bladder.
Zhu B; Ekman M; Svensson D; Lindvall JM; Nilsson BO; Uvelius B; Swärd K
Am J Physiol Renal Physiol; 2018 May; 314(5):F893-F905. PubMed ID: 29357417
[TBL] [Abstract][Full Text] [Related]
6. Cthrc1, a novel circulating hormone regulating metabolism.
Stohn JP; Perreault NG; Wang Q; Liaw L; Lindner V
PLoS One; 2012; 7(10):e47142. PubMed ID: 23056600
[TBL] [Abstract][Full Text] [Related]
7. The involvement of collagen triple helix repeat containing 1 in muscular dystrophies.
Spector I; Zilberstein Y; Lavy A; Genin O; Barzilai-Tutsch H; Bodanovsky A; Halevy O; Pines M
Am J Pathol; 2013 Mar; 182(3):905-16. PubMed ID: 23274062
[TBL] [Abstract][Full Text] [Related]
8. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
9. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
[TBL] [Abstract][Full Text] [Related]
10. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.
Weise-Cross L; Taylor JM; Mack CP
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2374-83. PubMed ID: 26381868
[TBL] [Abstract][Full Text] [Related]
12. Activated CTHRC1 promotes glycolysis in endothelial cells: Implications for metabolism and angiogenesis.
Toomey BH; Mitrovic SA; Lindner-Liaw M; Leon Vazquez RG; Kacer D; Ryzhov S; Prudovsky I; Lindner V
Vascul Pharmacol; 2023 Dec; 153():107246. PubMed ID: 38040222
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
[TBL] [Abstract][Full Text] [Related]
15. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
16. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
17. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
Binks AP; Beyer M; Miller R; LeClair RJ
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
[TBL] [Abstract][Full Text] [Related]
18. Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid.
Li J; Cao J; Li M; Yu Y; Yang Y; Xiao X; Wu Z; Wang L; Tu Y; Chen H
Br J Dermatol; 2011 May; 164(5):1030-6. PubMed ID: 21667528
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
[TBL] [Abstract][Full Text] [Related]
20. The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis.
Mei D; Zhu Y; Zhang L; Wei W
Mediators Inflamm; 2020; 2020():9578701. PubMed ID: 32848510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]